41Indexed trials
mesh condition
Depressive Disorder
Intelligence
Depressive Disorder intelligence: 41 indexed trials, 10 recruiting studies, 38 sponsors across 13 countries.
10Recruiting
38Sponsors
13Countries
Leading sponsors
University Hospital, Strasbourg, France20 recruiting
University of Oxford21 recruiting
GlaxoSmithKline20 recruiting
Beijing HuiLongGuan Hospital11 recruiting
Dana-Farber Cancer Institute10 recruiting
Eli Lilly and Company10 recruiting
Chen Li10 recruiting
George Washington University10 recruiting
First Affiliated Hospital of Chongqing Medical University10 recruiting
H. Lundbeck A/S10 recruiting
Indiana University10 recruiting
California Institute of Technology11 recruiting
Geographic activity
United States14trials
United Kingdom4trials
China4trials
Australia3trials
Canada3trials
Turkey (Türkiye)2trials
Israel1trials
Nepal1trials
Russia1trials
Spain1trials
France1trials
Germany1trials
Leading interventions
Ketamine2trials
Blended intervention (UP-APP)1trials
Classical rTMS (transcranial magnetic stimulation)1trials
Brainsway H7-Coil Deep TMS System1trials
Chinese translated LETS ACT1trials
Citalopram1trials
Brainsway H4-Coil Deep TMS System1trials
Classical tDCS (transcranial direct current stimulation)1trials
Cognitive Behavioral Therapy (CBT) in a Group Format1trials
Cognitive Behavioral Therapy (TAU)1trials
Duloxetine Hydrochloride1trials
Behavioral task performance1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.